Abionic
Abionic
Abionic (pronunciation: /æbɪˈɒnɪk/) is a term used in the field of biotechnology to refer to the application of nanotechnology in the diagnosis of diseases. The term is derived from the prefix 'abi-', meaning 'life', and the suffix '-onic', which is often used in the names of electronic devices and technologies.
Abionic technology is used in the development of diagnostic tests that can provide results in a matter of minutes, as opposed to traditional methods that can take hours or even days. This rapid diagnosis can be crucial in the treatment of certain conditions, such as sepsis and allergies, where early detection can significantly improve patient outcomes.
History
The concept of abionic technology was first introduced by the Swiss company Abionic SA, which was founded in 2010. The company developed the world's first nanofluidic biosensor, which uses a combination of nanotechnology and biotechnology to provide rapid diagnostic results.
Applications
Abionic technology is used in a variety of medical applications, including:
- Allergy testing: Abionic's nanofluidic biosensor can test for a wide range of allergens in just a few minutes, allowing for immediate diagnosis and treatment.
- Sepsis detection: The biosensor can also detect biomarkers associated with sepsis, a potentially life-threatening condition that requires immediate treatment.
- Personalized medicine: By providing rapid diagnostic results, abionic technology can help doctors tailor treatments to individual patients, improving outcomes and reducing healthcare costs.
See Also
External links
- Medical encyclopedia article on Abionic
- Wikipedia's article - Abionic
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski